• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.HLAMatchmaker:一种基于分子的组织相容性测定算法。五、HLA-DR、HLA-DQ和HLA-DP的表位匹配
Hum Immunol. 2007 Jan;68(1):12-25. doi: 10.1016/j.humimm.2006.10.003. Epub 2006 Oct 30.
2
Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.再次移植候选者具有与结构明确的人类白细胞抗原-DR、-DQ、-DP表位发生反应的供者特异性抗体。
Transpl Immunol. 2008 Feb;18(4):352-60. doi: 10.1016/j.trim.2007.10.001. Epub 2007 Oct 30.
3
Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.寺崎(Terasaki)的人类白细胞抗原(HLA)II类表位与HLA匹配器(HLAMatchmaker)定义的HLA-DR和-DQ抗原上的表位之间的相关性。
Tissue Antigens. 2009 Aug;74(2):134-46. doi: 10.1111/j.1399-0039.2009.01272.x. Epub 2009 Jun 2.
4
A structurally based approach to determine HLA compatibility at the humoral immune level.一种基于结构的方法,用于在体液免疫水平确定HLA相容性。
Hum Immunol. 2006 Nov;67(11):847-62. doi: 10.1016/j.humimm.2006.08.001. Epub 2006 Sep 1.
5
First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry.HLA表位登记处记录的HLA-DR、HLA-DQ和HLA-DP表位抗体验证的首次报告。
Hum Immunol. 2014 Nov;75(11):1097-103. doi: 10.1016/j.humimm.2014.09.012. Epub 2014 Oct 13.
6
Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.寺崎(Terasaki)的HLA I类表位与HLAMatchmaker定义的HLA-A、-B和-C抗原上的表位之间的相关性。
Tissue Antigens. 2009 Aug;74(2):117-33. doi: 10.1111/j.1399-0039.2009.01271.x. Epub 2009 Jun 2.
7
Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.红娘,红娘,给我牵根线:移植中优化 HLA 肽段相容性的机遇与挑战。
Int J Immunogenet. 2021 Apr;48(2):135-144. doi: 10.1111/iji.12525. Epub 2021 Jan 10.
8
HLA epitope based matching for transplantation.基于HLA表位的移植配型
Transpl Immunol. 2014 Jun;31(1):1-6. doi: 10.1016/j.trim.2014.04.004. Epub 2014 Apr 25.
9
Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support?HLA 致敏血小板减少症患者的结构表位匹配:提供更有效血小板输血支持的新策略?
Transfusion. 2008 Feb;48(2):221-7. doi: 10.1111/j.1537-2995.2007.01516.x. Epub 2007 Nov 13.
10
Antibody-defined epitopes on HLA-DQ alleles reacting with antibodies induced during pregnancy and the design of a DQ eplet map.与孕期诱导产生的抗体发生反应的HLA-DQ等位基因上的抗体定义表位及DQ表位图谱的设计
Hum Immunol. 2016 Oct;77(10):824-831. doi: 10.1016/j.humimm.2016.06.021. Epub 2016 Jun 29.

引用本文的文献

1
High-dimensional flow cytometry reveals lymphocyte subset populations predictive of chronic lung allograft dysfunction.高维流式细胞术揭示了可预测慢性肺移植功能障碍的淋巴细胞亚群。
Clin Transl Immunology. 2025 May 23;14(5):e70035. doi: 10.1002/cti2.70035. eCollection 2025.
2
Belimumab to Aid Pre-Transplant Immunological Risk-Stratification by Uncovering Broader HLA-Specific Memory B-Cell Profiles.贝利尤单抗通过揭示更广泛的 HLA 特异性记忆 B 细胞谱来辅助移植前免疫风险分层。
HLA. 2025 Jun;105(6):e70285. doi: 10.1111/tan.70285.
3
Cross-organ hierarchy of HLA molecular mismatches in donor-specific antibody development in solid organ transplantations.实体器官移植中供者特异性抗体产生过程中HLA分子错配的跨器官层级关系
Cell Rep Med. 2025 Jun 17;6(6):102153. doi: 10.1016/j.xcrm.2025.102153. Epub 2025 May 30.
4
Advancing risk stratification in kidney transplantation: integrating HLA-derived T-cell epitope and B-cell epitope matching algorithms for enhanced predictive accuracy of HLA compatibility.推进肾移植中的风险分层:整合源自人类白细胞抗原(HLA)的T细胞表位和B细胞表位匹配算法以提高HLA相容性的预测准确性
Front Immunol. 2025 Feb 11;16:1548934. doi: 10.3389/fimmu.2025.1548934. eCollection 2025.
5
Anti-Human Leukocyte Antigen Antibody Detection from Terasaki's Humoral Theory to Delisting Strategies in 2024.从寺崎的体液理论到2024年退市策略的抗人白细胞抗原抗体检测
Int J Mol Sci. 2025 Jan 13;26(2):630. doi: 10.3390/ijms26020630.
6
Novel Aspects of Immunogenetics and Post-Transplant Events in Kidney Transplantation.肾移植中免疫遗传学及移植后事件的新进展
Transpl Int. 2024 Dec 5;37:13317. doi: 10.3389/ti.2024.13317. eCollection 2024.
7
Genome-wide meta-analysis associates donor-recipient non-HLA genetic mismatch with acute cellular rejection post-liver transplantation.全基因组荟萃分析表明,供体-受体非人类白细胞抗原(HLA)基因错配与肝移植后急性细胞排斥反应相关。
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000601. eCollection 2025 Jan 1.
8
HLA-EpiCheck: novel approach for HLA B-cell epitope prediction using 3D-surface patch descriptors derived from molecular dynamic simulations.HLA-EpiCheck:一种使用源自分子动力学模拟的3D表面补丁描述符预测HLA B细胞表位的新方法。
Bioinform Adv. 2024 Dec 5;4(1):vbae186. doi: 10.1093/bioadv/vbae186. eCollection 2024.
9
Improving long-term kidney allograft survival by rethinking HLA compatibility: from molecular matching to non-HLA genes.通过重新思考HLA相容性提高肾移植长期存活率:从分子匹配到非HLA基因
Front Genet. 2024 Oct 2;15:1442018. doi: 10.3389/fgene.2024.1442018. eCollection 2024.
10
HLA-DR/DQ eplet mismatch predicts donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens.HLA-DR/DQ表位错配可预测不同免疫抑制方案下多民族东南亚肾移植受者体内供体特异性抗体的产生。
Front Genet. 2024 Aug 28;15:1447141. doi: 10.3389/fgene.2024.1447141. eCollection 2024.

本文引用的文献

1
14th International HLA and Immunogenetics Workshop: report on the structural basis of HLA compatibility.第14届国际人类白细胞抗原与免疫遗传学研讨会:关于人类白细胞抗原相容性结构基础的报告
Tissue Antigens. 2007 Apr;69 Suppl 1:180-4. doi: 10.1111/j.1399-0039.2006.00766.x.
2
A structurally based approach to determine HLA compatibility at the humoral immune level.一种基于结构的方法,用于在体液免疫水平确定HLA相容性。
Hum Immunol. 2006 Nov;67(11):847-62. doi: 10.1016/j.humimm.2006.08.001. Epub 2006 Sep 1.
3
Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.HLAMatchmaker和单抗原HLA抗体检测微珠在识别等待肾移植的高敏患者中可接受错配方面的效用。
Transplantation. 2006 May 15;81(9):1331-6. doi: 10.1097/01.tp.0000205202.56915.f5.
4
Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort.在以非裔美国人为主的肾移植队列中,使用HLAMatchmaker进行人类白细胞抗原表位匹配对移植结果的预测价值。
Clin Transplant. 2006 Mar-Apr;20(2):226-33. doi: 10.1111/j.1399-0012.2005.00473.x.
5
Detection of antibodies to HLA-DP in renal transplant recipients using single antigen beads.使用单抗原珠检测肾移植受者中针对HLA-DP的抗体。
Transplantation. 2005 Nov 27;80(10):1511-3. doi: 10.1097/01.tp.0000181384.49832.3a.
6
HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.由HLAMatchmaker驱动的对同种免疫性血小板减少症患者HLA分型血小板输注反应的分析。
Blood. 2006 Feb 15;107(4):1680-7. doi: 10.1182/blood-2004-10-4080. Epub 2005 Nov 3.
7
Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies.肽对人HLA抗体识别HLA I类分子的影响。
J Immunol. 2005 Nov 1;175(9):5950-7. doi: 10.4049/jimmunol.175.9.5950.
8
HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.基于人源单克隆抗体反应性的HLAMatchmaker分析表明,三联体定义表位的特异性识别存在一个额外接触位点的重要性。
Hum Immunol. 2005 Jul;66(7):749-61. doi: 10.1016/j.humimm.2005.04.002.
9
Extending options for highly sensitized patients to receive a suitable kidney graft.为高敏患者提供更多选择,使其能够接受合适的肾移植。
Curr Opin Immunol. 2005 Oct;17(5):536-40. doi: 10.1016/j.coi.2005.07.010.
10
Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches.移植肾切除术后的血清分析显示,针对结构明确的HLA I类错配的抗体特异性模式受限。
Transpl Immunol. 2005 Mar;14(1):53-62. doi: 10.1016/j.trim.2005.01.001.

HLAMatchmaker:一种基于分子的组织相容性测定算法。五、HLA-DR、HLA-DQ和HLA-DP的表位匹配

HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

作者信息

Duquesnoy Rene J, Askar Medhat

机构信息

Division of Transplantation Pathology, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA.

出版信息

Hum Immunol. 2007 Jan;68(1):12-25. doi: 10.1016/j.humimm.2006.10.003. Epub 2006 Oct 30.

DOI:10.1016/j.humimm.2006.10.003
PMID:17207708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2527859/
Abstract

This report describes the design of the eplet version of HLAMatchmaker to determine class II compatibility at the structural level. This matching algorithm is based on the hypothesis, developed from molecular modeling of crystallized antigen-antibody complexes, that functional epitopes are represented by patches of surface-exposed nonself-amino acid residues surrounded by residues within a 3-A radius. Patch determinations with a molecular viewer of crystalline structural models downloaded from the Entrez Molecular Modeling Database Web site led to the identification of 44 DRB, 33DQB, 29 DQA, 20 DPB, and 9 DPA unique combinations of polymorphic positions. The residue compositions of these patches were then determined from amino acid sequences. This analysis resulted in a repertoire of 146 DRB, 74 DQB, 58 DQA, 45 DPB, and 19 DPA eplets. In many eplets, the residues are in short linear sequences, but many other eplets have discontinuous sequences of residues that cluster on or near the molecular surface. This analysis has also shown that all serologically defined DR and DQ antigens detectable by monospecific antibodies have unique eplets. Other eplets are present in groups of class II antigens, many of which appear as cross-reacting. The eplet version of HLAMatchmaker should be considered as a hypothetical model for the structural assessment of donor-recipient compatibility and the determination of mismatch acceptability for sensitized patients. This computer algorithm can be downloaded from the HLA Matchmaker Webside at http://tpis.upmc.edu.

摘要

本报告描述了HLAMatchmaker的表位版本设计,以在结构水平上确定II类相容性。这种匹配算法基于从结晶抗原-抗体复合物的分子建模发展而来的假设,即功能性表位由表面暴露的非自身氨基酸残基斑块表示,这些斑块被半径为3埃的残基包围。使用从Entrez分子建模数据库网站下载的晶体结构模型的分子查看器进行斑块测定,从而确定了44个DRB、33个DQB、29个DQA、20个DPB和9个DPA多态性位置的独特组合。然后从氨基酸序列确定这些斑块的残基组成。该分析产生了146个DRB、74个DQB、58个DQA、45个DPB和19个DPA表位。在许多表位中,残基呈短线性序列,但许多其他表位具有在分子表面或其附近聚集的不连续残基序列。该分析还表明,所有可通过单特异性抗体检测到的血清学定义的DR和DQ抗原都有独特的表位。其他表位存在于II类抗原组中,其中许多表现为交叉反应。HLAMatchmaker的表位版本应被视为供体-受体相容性结构评估和致敏患者错配可接受性测定的假设模型。该计算机算法可从HLA Matchmaker网站http://tpis.upmc.edu下载。